AbbVie (ABBV) Revenue — Quarter Ended Jun 30, 2025
AbbVie's revenue rose in the latest quarter. The increase was supported by higher net revenues, as highlighted in the company's operating cash flow analysis.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
AbbVie's revenue rose in the latest quarter. The increase was supported by higher net revenues, as highlighted in the company's operating cash flow analysis.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$15.4B
Revenue reported for this quarter.
Quarter-over-quarter
+15.6%
Change from the immediately preceding quarter.
Year-over-year
+6.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$58.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $14.5B | +3.8% |
| Dec 31, 2024 | $15.1B | +5.6% |
| Mar 31, 2025 | $13.3B | +8.4% |
| Jun 30, 2025 | $15.4B | +6.6% |
Revenue performance
Revenue increased compared to the immediately preceding quarter. It also rose versus the same quarter one year earlier.
Quarterly comparison
The sequential improvement reflects a stronger quarter, while the year-over-year gain indicates continued positive momentum.
What to watch
Higher litigation-related payments partially offset operating cash flow gains, which may warrant attention.